Amazon is making a big bet on generative artificial intelligence — and its use in healthcare — with a $4 billion investment in AI company Anthropic.
The tech giant will take a minority ownership in the startup and incorporate Anthropic's AI assistant, Claude, into Amazon Bedrock, Amazon Web Services' new generative AI service.
"This is important for healthcare and life sciences organizations, as we're seeing AWS customers look to employ Anthropic's Claude generative AI models via Amazon Bedrock to improve drug development and healthcare services," an AWS spokesperson emailed Becker's on Sept. 25.
The move ups the competition in the healthcare generative AI space. Microsoft has reportedly invested $13 billion in OpenAI, the maker of ChatGPT, and subsequently partnered with Epic and health systems to draft patient portal messages for clinicians.
Amazon said Claude is "much less likely to produce harmful outputs, easier to converse with, and more steerable" than other AI chatbots and can securely process "technical, domain-specific documents for industries such as finance, legal, and healthcare."